{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T22:24:06Z","timestamp":1743978246898},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2013,12,10]],"date-time":"2013-12-10T00:00:00Z","timestamp":1386633600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0082082","type":"journal-article","created":{"date-parts":[[2013,12,10]],"date-time":"2013-12-10T21:29:42Z","timestamp":1386710982000},"page":"e82082","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Calcium Channel Blocker Enhances Beneficial Effects of an Angiotensin II AT1 Receptor Blocker against Cerebrovascular-Renal Injury in type 2 Diabetic Mice"],"prefix":"10.1371","volume":"8","author":[{"given":"Kazi","family":"Rafiq","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shamshad J.","family":"Sherajee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Hitomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Kobori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Ohmori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirohito","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Kobara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Masaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakazu","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,12,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1056\/NEJMoa010713","article-title":"A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure","volume":"345","author":"JN Cohn","year":"2001","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa032292","article-title":"Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both","volume":"349","author":"MA Pfeffer","year":"2003","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1056\/NEJMoa011489","article-title":"The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes","volume":"345","author":"HH Parving","year":"2001","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/ki.2012.326","article-title":"An angiotensin II receptor blocker-calcium channel blocker combination prevents cardiovascular events in elderly high-risk hypertensive patients with chronic kidney disease better than high-dose angiotensin II receptor blockade alone","volume":"83","author":"S Kim-Mitsuyama","year":"2013","journal-title":"Kidney Int"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","volume":"42","author":"AV Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"ref6","first-page":"1462","article-title":"2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"28","author":"G Mancia","year":"2007","journal-title":"Eur Heart J"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/hr.2009.34","article-title":"The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)","volume":"32","author":"T Ogihara","year":"2009","journal-title":"Hypertens Res"},{"key":"ref8","first-page":"1281","article-title":"2013 ESH\/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"31","author":"G Mancia","year":"2013"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/08037051.2013.812549","article-title":"2013 ESH\/ESC Guidelines for the management of arterial hypertension","volume":"22","author":"G Mancia","year":"2013","journal-title":"Blood Press"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/bmj.39548.738368.BE","article-title":"Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials","volume":"336","author":"F Turnbull","year":"2008","journal-title":"BMJ"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1586\/erc.09.47","article-title":"Blocking the renin-angiotensin system: dual- versus mono-therapy","volume":"7","author":"A Ravandi","year":"2009","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1056\/NEJMoa0806182","article-title":"Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients","volume":"359","author":"K Jamerson","year":"2008","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.amjmed.2011.12.010","article-title":"Angiotensin II receptor blocker-based therapy in Japanese elderly, high-risk, hypertensive patients","volume":"125","author":"H Ogawa","year":"2012","journal-title":"Am J Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1523-1755.2005.00397.x","article-title":"Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study","volume":"68","author":"T Ninomiya","year":"2005","journal-title":"Kidney Int"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ajh.2008.291","article-title":"Large artery stiffening as a link between cerebral lacunar infarction and renal albuminuria","volume":"21","author":"J Hashimoto","year":"2008","journal-title":"Am J Hypertens"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/hr.2012.108","article-title":"An increase in perfusion pressure and activation of the renin-angiotensin system in the pathogenesis of hypertension and injury: strain vessels and the cerebrovascular-renal connection","volume":"35","author":"K Tamura","year":"2012","journal-title":"Hypertens Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/hr.2012.112","article-title":"Albuminuria indicates the pressure-associated injury of juxtamedullary nephrons and cerebral strain vessels in spontaneously hypertensive stroke-prone rats","volume":"35","author":"T Nagasawa","year":"2012","journal-title":"Hypertens Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jns.2007.01.066","article-title":"Microalbuminuria is a risk factor for cerebral small vessel disease in community-based elderly subjects","volume":"255","author":"M Wada","year":"2007","journal-title":"J Neurol Sci"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1053\/j.ajkd.2010.03.018","article-title":"Silent brain infarction and rapid decline of kidney function in patients with CKD: a prospective cohort study","volume":"56","author":"M Kobayashi","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1212\/WNL.0b013e318259e110","article-title":"Proteinuria and clinical outcomes after ischemic stroke","volume":"78","author":"Y Kumai","year":"2012","journal-title":"Neurology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1136\/bmj.38446.466238.E0","article-title":"Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study","volume":"330","author":"RA Whitmer","year":"2005","journal-title":"BMJ"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1001\/jama.292.18.2237","article-title":"The metabolic syndrome, inflammation, and risk of cognitive decline","volume":"292","author":"K Yaffe","year":"2004","journal-title":"JAMA"},{"key":"ref23","first-page":"2011","article-title":"Vascular pathology and blood-brain barrier disruption in cognitive and psychiatric complications of type 2 diabetes mellitus","author":"Y Serlin","year":"2011","journal-title":"Cardiovasc Psychiatry Neurol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1053\/j.ackd.2005.01.008","article-title":"Tubular changes in early diabetic nephropathy","volume":"12","author":"MC Thomas","year":"2005","journal-title":"Adv Chronic Kidney Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1124\/jpet.106.108894","article-title":"Calcium channel blocker azelnidipine reduces glucose intolerance in diabetic mice via different mechanism than angiotensin receptor blocker olmesartan","volume":"319","author":"M Iwai","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1161\/CIRCULATIONAHA.111.064097","article-title":"Renal sympathetic denervation suppresses de novo podocyte injury and albuminuria in rats with aortic regurgitation","volume":"125","author":"K Rafiq","year":"2012","journal-title":"Circulation"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1161\/HYPERTENSIONAHA.107.099374","article-title":"Amelioration of cognitive impairment in the type-2 diabetic mouse by the angiotensin II type-1 receptor blocker candesartan","volume":"50","author":"K Tsukuda","year":"2007","journal-title":"Hypertension"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.neuropharm.2007.08.020","article-title":"Inhibition of cognitive decline in mice fed a high-salt and cholesterol diet by the angiotensin receptor blocker, olmesartan","volume":"53","author":"M Mogi","year":"2007","journal-title":"Neuropharmacology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.brainres.2011.07.020","article-title":"The effects of hyperbaric oxygen therapy on blood-brain barrier permeability in septic rats","volume":"1412","author":"SM Avtan","year":"2011","journal-title":"Brain Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.neuint.2011.01.018","article-title":"Arginine-vasopressin V1a receptor inhibition improves neurologic outcomes following an intracerebral hemorrhagic brain injury","volume":"58","author":"A Manaenko","year":"2011","journal-title":"Neurochem Int"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/HJH.0b013e32834103a9","article-title":"Effects of mineralocorticoid receptor blockade on glucocorticoid-induced renal injury in adrenalectomized rats","volume":"29","author":"K Rafiq","year":"2011","journal-title":"J Hypertens"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/ATVBAHA.111.240697","article-title":"Aldosterone induces vascular insulin resistance by increasing insulin-like growth factor-1 receptor and hybrid receptor","volume":"32","author":"SJ Sherajee","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1124\/jpet.106.105106","article-title":"Effects of adrenomedullin on cardiac oxidative stress and collagen accumulation in aldosterone-dependent malignant hypertensive rats","volume":"318","author":"M Rahman","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1161\/STROKEAHA.110.597997","article-title":"Validation of in vivo magnetic resonance imaging blood-brain barrier permeability measurements by comparison with gold standard histology","volume":"42","author":"A Hoffmann","year":"2011","journal-title":"Stroke"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1124\/jpet.109.158113","article-title":"Mineralocorticoid receptor blockade enhances the antiproteinuric effect of an angiotensin II blocker through inhibiting podocyte injury in type 2 diabetic rats","volume":"332","author":"A Nishiyama","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1097\/01.hjh.0000244952.54738.f6","article-title":"The calcium-channel blocker, azelnidipine, enhances the inhibitory action of AT1 receptor blockade on ischemic brain damage","volume":"24","author":"M Iwai","year":"2006","journal-title":"J Hypertens"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1161\/01.HYP.0000113627.08110.6f","article-title":"Calcium channel blocker azelnidipine enhances vascular protective effects of AT1 receptor blocker olmesartan","volume":"43","author":"T Jinno","year":"2004","journal-title":"Hypertension"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1124\/mol.104.008144","article-title":"Effect of azelnidipine on angiotensin II-mediated growth-promoting signaling in vascular smooth muscle cells","volume":"67","author":"JM Li","year":"2005","journal-title":"Mol Pharmacol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jns.2009.02.321","article-title":"Blood-brain barrier alterations in ageing and dementia","volume":"283","author":"BO Popescu","year":"2009","journal-title":"J Neurol Sci"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/ajh.2010.241","article-title":"Blockade of AT1 receptors protects the blood-brain barrier and improves cognition in Dahl salt-sensitive hypertensive rats","volume":"24","author":"N Pelisch","year":"2011","journal-title":"Am J Hypertens"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1254\/jphs.12031FP","article-title":"Add-On Aliskiren Elicits Stronger Renoprotection Than High-Dose Valsartan in Type 2 Diabetic KKAy Mice That Do Not Respond to Low-Dose Valsartan","volume":"119","author":"B Lei","year":"2012","journal-title":"J Pharmacol Sci"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/ajh.2012.1","article-title":"Early treatment with olmesartan prevents juxtamedullary glomerular podocyte injury and the onset of microalbuminuria in type 2 diabetic rats","volume":"25","author":"T Sofue","year":"2012","journal-title":"Am J Hypertens"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"8526","DOI":"10.1073\/pnas.1332809100","article-title":"Reversal of age-related learning deficits and brain oxidative stress in mice with superoxide dismutase\/catalase mimetics","volume":"100","author":"R Liu","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref44","first-page":"1152","article-title":"Evidence of increased oxidative damage in subjects with mild cognitive impairment","volume":"64","author":"JN Keller","year":"2005"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"F619","DOI":"10.1152\/ajprenal.00388.2002","article-title":"Effect of salt on hypertension and oxidative stress in a rat model of diet-induced obesity","volume":"285","author":"AD Dobrian","year":"2003","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/hr.2011.67","article-title":"Additive antioxidative effects of azelnidipine on angiotensin receptor blocker olmesartan treatment for type 2 diabetic patients with albuminuria","volume":"34","author":"M Abe","year":"2011","journal-title":"Hypertens Res"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"M Brownlee","year":"2001","journal-title":"Nature"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/jcla.20328","article-title":"Oxidative damage to DNA and lipids: correlation with protein glycation in patients with type 1 diabetes","volume":"24","author":"MT Goodarzi","year":"2010","journal-title":"J Clin Lab Anal"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1097\/01.hjh.0000173521.91104.5f","article-title":"Effect of combination of calcium antagonist, azelnidipine, and AT1 receptor blocker, olmesartan, on atherosclerosis in apolipoprotein E-deficient mice","volume":"23","author":"J Suzuki","year":"2005","journal-title":"J Hypertens"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1124\/jpet.105.095331","article-title":"Effects of calcium channel blockade on angiotensin II-induced peritubular ischemia in rats","volume":"316","author":"N Kondo","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1177\/0960327112464798","article-title":"Polychlorinated biphenyls impair blood-brain barrier integrity via disruption of tight junction proteins in cerebrum, cerebellum and hippocampus of female Wistar rats: neuropotential role of quercetin","volume":"32","author":"K Selvakumar","year":"2013","journal-title":"Hum Exp Toxicol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ijdevneu.2008.05.002","article-title":"Protective role of melatonin on PCB (Aroclor 1,254) induced oxidative stress and changes in acetylcholine esterase and membrane bound ATPases in cerebellum, cerebral cortex and hippocampus of adult rat brain","volume":"26","author":"P Venkataraman","year":"2008","journal-title":"Int J Dev Neurosci"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0082082","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T23:57:46Z","timestamp":1540339066000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0082082"}},"subtitle":[],"editor":[{"given":"Maria\u00a0A.","family":"Deli","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,12,10]]},"references-count":52,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2013,12,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0082082","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,10]]}}}